North America Metagenomics Market to 2027- Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country
- THE3206955
- 139 Pages
- February 2019
- Diagnostic and Biotech
Metagenomics is the upcoming field of the biotechnology and the extensive researches are being conducted in the labs across the world. Several clinical labs in United States, have already undertaken the considerable lengths to upgrade and validate a wide range of protocols for agnostically detecting viral, bacterial, fungal and eukaryotic parasite nucleic acid in different specimens of patient to benefit in diagnosis for particularly intractable cases.
The extensive research need is pushing the venture capitals or academic medical centers to subsidize the prices for the metagenomics testing. They help to conduct researches to carry out testing in US$ 2000 - US$ 3000 per sample.
Major market players such as Illumina based in California have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing. For instance, Illumina's NovaSeq 6000 Sequencing System releases groundbreaking innovations. The system enables accessible throughput and flexibility for virtually any sequencing method, genome and scale of project.
Owing to factor that the cost of the metagenomics is been subsidize by the venture capitalists and the innovative technology by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.
US is anticipated to lead the adoptions of Metagenomics across the North American region through the forecast period. The major players headquartered in the US are also focused towards developing innovative and novel products and bringing them into market, which is also one of the major factors driving the growth of US in the North America metagenomics market. Moreover, the companies are significantly investing under research and development to come-up with medical products that are derived from natural microbial sources. For instance, in August 2018, Genentech and Lodo initiated a US$ 1 Bn project to develop unique, natural products from the microbial DNA found in soil. Under the collaboration, Genentech will use Lodo's metagenome-prospecting platform to identify novel small molecules with the potential for treating disease.
Exhibit: Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Bn)
NORTH AMERICA METAGENOMICS - MARKET SEGMENTATION
By Product
Instruments & Software
Consumables
NORTH AMERICA METAGENOMICS - MARKET SEGMENTATION
By Application
Clinical Diagnostics
Drug Discovery
By Country
U.S.
Canada
Mexico
Companies Mentioned
Merck KGaA
Thermo Fisher Scientific Inc.
Agilent Technologies
Qiagen
Bio-Rad Laboratories, Inc.
Perkinelmer Inc.
Illumina Inc.
F Hoffman-La Roche Ltd.
Oxford Nanopore Technologies Ltd.
Pacific Bioscience of California, Inc.
PART 1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
PART 2. NORTH AMERICA METAGENOMICS MARKET - KEY TAKEAWAYS
PART 3. NORTH AMERICA METAGENOMICS MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 North America Metagenomics Market - By Product
3.2.2 North America Metagenomics Market - By Application
3.2.3 North America Metagenomics Market - By Country
3.3 PEST ANALYSIS
3.3.1 North America - PEST Analysis
PART 4. NORTH AMERICA METAGENOMICS MARKET- KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing Investments in the field of Metagenomics
4.1.2 Benefits of Metagenomics Over Traditional Methods
4.1.3 Diverse Potential Applications of Metagenomics
4.2 KEY MARKET RESTRAINTS
4.2.1 High Cost Associated With Metagenomics
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Precision Metagenomic Analysis In Personalised Medicine
4.4 KEY MARKET TRENDS
4.4.1 Growing Trend of Molecular-Based Approaches
4.5 IMPACT ANALYSIS
PART 5. METAGENOMICS MARKET - NORTH AMERICA ANALYSIS
5.1 NORTH AMERICA METAGENOMICS MARKET REVENUE FORECASTS AND ANALYSIS
5.2 MARKET POSITIONING
5.3 PERFORMANCE OF KEY PLAYERS
Illumina, Inc.
Qiagen
5.4 EXPERT OPINIONS
PART 6. NORTH AMERICA METAGENOMICS MARKET ANALYSIS - BY PRODUCT
6.1 OVERVIEW
6.2 NORTH AMERICA METAGENOMICS MARKET, BY PRODUCT, 2018 & 2027 (%)
6.3 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
6.4 INSTRUMENTS & SOFTWARE MARKET
6.4.1 Overview
6.4.2 North America Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 CONSUMABLES MARKET
6.5.1 Overview
6.5.2 North America Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
PART 7. NORTH AMERICA METAGENOMICS MARKET ANALYSIS - BY APPLICATION
7.1 OVERVIEW
7.2 NORTH AMERICA METAGENOMICS MARKET, BY APPLICATION, 2018 & 2027 (%)
7.3 CLINICAL DIAGNOSTIC MARKET
7.3.1 Overview
7.3.2 North America Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 DRUG DISCOVERY METAGENOMICS MARKET
7.4.1 Overview
7.4.2 North America Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 OTHERS MARKET
7.5.1 Overview
7.5.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
PART 8. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
8.1 OVERVIEW
8.2 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
8.3 US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3.1 US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.2 US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.3 US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.4 CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.1 Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.2 Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.4.3 Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.5 MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.1 Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.2 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.5.3 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
PART 9. METAGENOMICS MARKET -INDUSTRY LANDSCAPE
9.1 OVERVIEW
9.2 GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
9.3 ORGANIC DEVELOPMENTS
9.3.1 Overview
9.4 ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
9.5 PRODUCT LAUNCH
9.5.1 Recent Product Launch By Players In The Metagenomics Market
9.6 PRODUCT APPROVAL
9.6.1 Recent Product Approval By Players In The Metagenomics Market
9.7 EXPANSION & OTHERS
9.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
9.8 INORGANIC DEVELOPMENTS
9.8.1 Overview
9.9 INORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
9.10 ACQUISITIONS
9.10.1 Acquisitions By Players In The Metagenomics Market
9.11 AGREEMENTS
9.11.1 The Metagenomics Market By Agreements
9.12 PARTNERSHIP & COLLABORATION
9.12.1 Partnership By Players In The Metagenomics Market
PART 10. METAGENOMICS MARKET-KEY COMPANY PROFILES
10.1 MERCK KGAA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 THERMO FISHER SCIENTIFIC, INC.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 AGILENT TECHNOLOGIES, INC.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 QIAGEN
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 BIO-RAD LABORATORIES, INC.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 PERKIN ELMER, INC.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 ILLUMINA, INC.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 F. HOFFMANN-LA ROCHE LTD.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 OXFORD NANOPORE TECHNOLOGIES LTD.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product & Services Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 PACIFIC BIOSCIENCE OF CALIFORNIA, INC.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product & Services Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. APPENDIX
11.1 ABOUT THE INSIGHT PARTNERS
11.2 GLOSSARY OF TERMS
11.3 METHODOLOGY
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
TABLE 1. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 2. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 3. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 4. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 5. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 6. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 7. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 8. RECENT PRODUCT LAUNCH IN THE METAGENOMICS MARKET
TABLE 9. RECENT PRODUCT APPROVAL AND ENHANCEMENTS IN THE METAGENOMICS MARKET
TABLE 10. THE METAGENOMICS MARKET BY EXANSION & OTHERS STRATEGIES
TABLE 11. ACQUISITIONS IN THE METAGENOMICS MARKET
TABLE 12. THE METAGENOMICS MARKET BY AGREEMENTS
TABLE 13. PARTNERSHIP IN THE METAGENOMICS MARKET
TABLE 14. GLOSSARY OF TERMS, METAGENOMICS MARKET
LIST OF FIGURES
FIGURE 1. US METAGENOMICS MARKET, REVENUE (US$ MN), BY 2018 & 2027
FIGURE 2. NORTH AMERICA METAGENOMICS MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 3. NORTH AMERICA METAGENOMICS MARKET BY APPLICATION, MARKET SHARE (%), 2018
FIGURE 4. METAGENOMICS MARKET SEGMENTATION
FIGURE 5. NORTH AMERICA PEST ANALYSIS
FIGURE 6. METAGENOMICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 7. NORTH AMERICA METAGENOMICS MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2027
FIGURE 8. NORTH AMERICA METAGENOMICS MARKET BY PRODUCT, 2018 & 2027 (%)
FIGURE 9. NORTH AMERICA INSTRUMENTS & SOFTWARE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 10. NORTH AMERICA CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 11. NORTH AMERICA METAGENOMICS MARKET BY APPLICATION, 2018 & 2027 (%)
FIGURE 12. NORTH AMERICA CLINICAL DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 13. NORTH AMERICA DRUG DISCOVERY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 14. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 15. NORTH AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 16. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 20. ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 21. INORGANIC DEVELOPMENTS IN THE METAGENOMICS MARKET, 2015-2018
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
